RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재 SCIE SCOPUS

      Effects of red ginseng oil(KGC11 o) on testosterone-propionate-induced benign prostatic hyperplasia

      한글로보기

      https://www.riss.kr/link?id=A108124102

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      Benign prostatic hyperplasia (BPH) is a disease characterized by abnormal proliferation ofthe prostate, which occurs frequently in middle-aged men. In this study, we report the effect of redginseng oil (KGC11o) on BPH.
      Methods: The BPH-induced Sprague-Dawley rats were divided into seven groups: control, BPH, KGC11o25, 50, 100, 200, and finasteride groups. KGC11o and finasteride were administered for 8 weeks. The BPHbiomarkers, DHT, 5AR1, and 5AR2, androgen receptor, prostate-specific antigen (PSA), Bax, Bcl-2, andTGF-b were determined in the serum and prostate tissue. The cell viability after KGC11o treatment wasdetermined using BPH-1 cells, and, androgen receptor, Bax, Bcl-2, and TGF-b were confirmed by westernblotting.
      Results: In the in vivo study, administration of KGC11o reduced prostate weight by 18%, suppressed DHT(up to 22%) and 5AR2 (up to 12%) levels from administration of 100 mg/kg KGC11o (P < 0.05). PSA wassignificantly downregulated dose-dependently from at the concentration of 50 mg/kg KGC11o (P < 0.05).
      BPH-1 cell viability significantly reduced through the treatment with KGC11o. In vitro and vivo, AR, Bcl-2TGF-b levels reduced significantly but Bax was increased (P < 0.05).
      Conclusion: These results suggest that KGC11o may inhibit the development of BPH by significantlyreducing the levels of BPH biomarkers via 5ARI, anti-androgenic effect, and anti-proliferation effect,serving as a potential functional food for treating BPH.
      번역하기

      Benign prostatic hyperplasia (BPH) is a disease characterized by abnormal proliferation ofthe prostate, which occurs frequently in middle-aged men. In this study, we report the effect of redginseng oil (KGC11o) on BPH. Methods: The BPH-induced Sprague...

      Benign prostatic hyperplasia (BPH) is a disease characterized by abnormal proliferation ofthe prostate, which occurs frequently in middle-aged men. In this study, we report the effect of redginseng oil (KGC11o) on BPH.
      Methods: The BPH-induced Sprague-Dawley rats were divided into seven groups: control, BPH, KGC11o25, 50, 100, 200, and finasteride groups. KGC11o and finasteride were administered for 8 weeks. The BPHbiomarkers, DHT, 5AR1, and 5AR2, androgen receptor, prostate-specific antigen (PSA), Bax, Bcl-2, andTGF-b were determined in the serum and prostate tissue. The cell viability after KGC11o treatment wasdetermined using BPH-1 cells, and, androgen receptor, Bax, Bcl-2, and TGF-b were confirmed by westernblotting.
      Results: In the in vivo study, administration of KGC11o reduced prostate weight by 18%, suppressed DHT(up to 22%) and 5AR2 (up to 12%) levels from administration of 100 mg/kg KGC11o (P < 0.05). PSA wassignificantly downregulated dose-dependently from at the concentration of 50 mg/kg KGC11o (P < 0.05).
      BPH-1 cell viability significantly reduced through the treatment with KGC11o. In vitro and vivo, AR, Bcl-2TGF-b levels reduced significantly but Bax was increased (P < 0.05).
      Conclusion: These results suggest that KGC11o may inhibit the development of BPH by significantlyreducing the levels of BPH biomarkers via 5ARI, anti-androgenic effect, and anti-proliferation effect,serving as a potential functional food for treating BPH.

      더보기

      참고문헌 (Reference)

      1 Jung Y, "Vanillic acid attenuates testosterone-induced benign prostatic hyperplasia in rats and inhibits proliferation of prostatic epithelial cells" 8 (8): 87194-87208, 2017

      2 Litwin MS, "Urologic diseases in America project : analytical methods and principal findings" 173 (173): 933-937, 2005

      3 Jinhyung Rho, "Ulmus macrocarpa Hance improves benign prostatic hyperplasia by regulating prostatic cell apoptosis" Elsevier BV 233 : 115-122, 2019

      4 Li F, "Transforming growth factor beta 1 impairs benign prostatic luminal epithelial cell monolayer barrier function" 8 (8): 9-17, 2020

      5 Webber R, "Therapeutic treatment for benign prostatic hyperplasia" 99 (99): 697-, 2007

      6 Heinlein CA, "The roles of androgen receptors and androgen-binding proteins in nongenomic androgen actions" 16 (16): 2181-2187, 2002

      7 Paolo Verze, "The role of the prostate in male fertility, health and disease" Springer Science and Business Media LLC 13 (13): 379-386, 2016

      8 Vickman RE, "The role of the androgen receptor in prostate development and benign prostatic hyperplasia : a review" 7 (7): 191-202, 2020

      9 Carson C, "The role of dihydrotestosterone in benign prostatic hyperplasia" 61 (61): 2-7, 2003

      10 Alisha Wehdnesday Bernardo Reyes, "The host immune enhancing agent Korean red ginseng oil successfully attenuates Brucella abortus infection in a murine model" Elsevier BV 198 : 5-14, 2017

      1 Jung Y, "Vanillic acid attenuates testosterone-induced benign prostatic hyperplasia in rats and inhibits proliferation of prostatic epithelial cells" 8 (8): 87194-87208, 2017

      2 Litwin MS, "Urologic diseases in America project : analytical methods and principal findings" 173 (173): 933-937, 2005

      3 Jinhyung Rho, "Ulmus macrocarpa Hance improves benign prostatic hyperplasia by regulating prostatic cell apoptosis" Elsevier BV 233 : 115-122, 2019

      4 Li F, "Transforming growth factor beta 1 impairs benign prostatic luminal epithelial cell monolayer barrier function" 8 (8): 9-17, 2020

      5 Webber R, "Therapeutic treatment for benign prostatic hyperplasia" 99 (99): 697-, 2007

      6 Heinlein CA, "The roles of androgen receptors and androgen-binding proteins in nongenomic androgen actions" 16 (16): 2181-2187, 2002

      7 Paolo Verze, "The role of the prostate in male fertility, health and disease" Springer Science and Business Media LLC 13 (13): 379-386, 2016

      8 Vickman RE, "The role of the androgen receptor in prostate development and benign prostatic hyperplasia : a review" 7 (7): 191-202, 2020

      9 Carson C, "The role of dihydrotestosterone in benign prostatic hyperplasia" 61 (61): 2-7, 2003

      10 Alisha Wehdnesday Bernardo Reyes, "The host immune enhancing agent Korean red ginseng oil successfully attenuates Brucella abortus infection in a murine model" Elsevier BV 198 : 5-14, 2017

      11 Kirby RS, "Terazosin in benign prostatic hyperplasia : effects on blood pressure in normotensive and hypertensive men" 82 (82): 373-379, 1998

      12 Lucy J. Schmidt, "Steroid 5 α-reductase inhibitors targeting BPH and prostate cancer" Elsevier BV 125 (125): 32-38, 2011

      13 Carvalho-Dias E, "Serotonin regulates prostate growth through androgen receptor modulation" 7 (7): 1-11, 2017

      14 박민지 ; 김규봉 ; 전미라 ; 정우식, "Safety of red ginseng oil for single oral administration in SpragueeDawley rats" 고려인삼학회 38 (38): 78-81, 2014

      15 Li C, "Resveratrol induces apoptosis of benign prostatic hyperplasia epithelial cell line(BPH-1)through p38 MAPK-FOXO3a pathway" 19 (19): 1-7, 2019

      16 Calais da Silva F, "Relative importance of sexuality and quality of life in patients with prostatic symptoms. Results of an international study" 31 (31): 272-280, 1997

      17 Jung-Soo Bae, "Red ginseng and 20(S)-Rg3 control testosterone-induced prostate hyperplasia by deregulating androgen receptor signaling" Springer Science and Business Media LLC 66 (66): 476-485, 2011

      18 Wijerathne CUB, "Quisqualis indica improves benign prostatic hyperplasia by regulating prostate cell proliferation and apoptosis" 40 (40): 2125-2133, 2017

      19 Kim HJ, "Psoralea corylifolia L. extract ameliorates benign prostatic hyperplasia by regulating prostate cell proliferation and apoptosis" 273 : 113844-, 2021

      20 Chen JL, "Precision medicine in the diagnosis and treatment of male lower urinary tract symptoms suggestive of benign prostatic hyperplasia, vol. 32" 5-13, 2020

      21 RatliffTL, "Pomegranate fruit juice for chemoprevention and chemotherapy of prostate cancer : Commentary" 175 (175): 1171-, 2006

      22 McNeal J, "Pathology of benign prostatic hyperplasia. Insight into etiology" 17 (17): 477-486, 1990

      23 Liu J, "Pao Pereira extract attenuates testosterone-induced benign prostatic hyperplasia in rats by inhibiting 5areductase" 9 (9): 1-10, 2019

      24 Kim IY, "Modulation of sensitivity to transforming growth factor-b1(TGF-b1)and the level of type II TGF-b receptor in LNCaP cells by dihydrotestosterone" 222 (222): 103-110, 1996

      25 El-mehi AE, "Modulating role of Panax Ginseng in experimentally induced benign prostatic hyperplasia in adult male albino rats (1)" 2 (2): 1031-, 2015

      26 Harman SM, "Longitudinal effects of aging on serum total and free testosterone levels in healthy men" 86 (86): 724-731, 2001

      27 Kim Y, "GV1001 interacts with androgen receptor to inhibit prostate cell proliferation in benign prostatic hyperplasia by regulating expression of molecules related to epithelialmesenchymal transition" 13 (13): 3202-3217, 2021

      28 Mysore V, "Finasteride and sexual side effects" 3 (3): 62-, 2012

      29 La Vignera S, "Endocrine control of benign prostatic hyperplasia" 4 (4): 404-411, 2016

      30 김소라 ; 하애화 ; 최현지 ; 김선림 ; 강현중 ; 김명환 ; 김우경, "Corn silk extract improves benign prostatic hyperplasia in experimental rat model" 한국영양학회 11 (11): 373-380, 2017

      31 Wilt TJ, "Beta-sitosterols for benign prostatic hyperplasia" (3) : CD001043-, 1999

      32 L. Vignozzi, "Benign prostatic hyperplasia: a new metabolic disease?" Springer Science and Business Media LLC 37 (37): 313-322, 2014

      33 McVary KT, "BPH : epidemiology and comorbidities" 12 (12): 122-128, 2006

      34 Bak MJ, "Antioxidant and hepatoprotective effects of the red ginseng essential oil in H 2O 2-treated HepG2 cells and CCL 4-treated mice" 13 (13): 2314-2330, 2012

      35 Lin GG, "Androgen receptor and growth factor signaling cross-talk in prostate cancer cells" 100 (100): 130-134, 2012

      36 Abdel-Aziz AM, "Amelioration of testosterone-induced benign prostatic hyperplasia using febuxostat in rats: the role of VEGF/TGFbeta and iNOS/COX-2" 889 : 173631-, 2020

      37 Park J, "Aconiti Lateralis radix preparata, the dried root of Aconitum carmichaelii Debx., improves benign prostatic hyperplasia via suppressing 5-alpha reductase and inducing prostate cell apoptosis" 6369132-, 2019

      38 Hyun Kyung Park, "A herbal formula, comprising Panax ginseng and bee-pollen, inhibits development of testosterone-induced benign prostatic hyperplasia in male Wistar rats" Elsevier BV 24 (24): 1555-1561, 2017

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2023 평가예정 해외DB학술지평가 신청대상 (해외등재 학술지 평가)
      2020-01-01 평가 등재학술지 유지 (해외등재 학술지 평가) KCI등재
      2011-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2009-04-07 학술지명변경 한글명 : 고려인삼학회지 -> Journal of Ginseng Research KCI등재
      2009-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2007-01-01 평가 등재 1차 FAIL (등재유지) KCI등재
      2004-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      2003-01-01 평가 등재후보 1차 PASS (등재후보1차) KCI등재후보
      2001-07-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 3.97 1.04 2.93
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      2.49 2.07 1.604 0.15
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼